๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Tamsulosin hydrochloride - Medicines in Ireland

27 authorised products containing Tamsulosin hydrochloride, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 27 authorised medicines
MedicineActive substanceLicence holderStatus
Combodart 0.5 mg/ 0.4 mg hard capsules
PA1077/118/001
Dutasteride, Tamsulosin hydrochloride GlaxoSmithKline (Ireland) Limited Marketed
Combodart 0.5 mg/ 0.4 mg hard capsules
PPA1463/068/001
Dutasteride, Tamsulosin hydrochloride IMED Healthcare Ltd., โ€”
Combodart 0.5 mg/ 0.4 mg hard capsules
PPA23080/025/001
Dutasteride, Tamsulosin hydrochloride Merit Pharmaceuticals Limited โ€”
Combodart 0.5 mg/0.4 mg hard capsules
PPA0465/334/001
Dutasteride, Tamsulosin hydrochloride PCO Manufacturing Ltd. โ€”
Dutasteride/Tamsulosin hydrochloride 0.5 mg /0.4 mg hard capsules
PA23266/045/001
Dutasteride, Tamsulosin hydrochloride Viatris Limited Marketed
Dutasteride/Tamsulosin Hydrochloride 0.5 mg/0.4 mg hard capsules
PA2315/222/001
Dutasteride, Tamsulosin hydrochloride Accord Healthcare Ireland Ltd. Marketed
Dutasteride/Tamsulosin hydrochloride Pinewood 0.5 mg/0.4 mg hard capsules
PA0281/216/001
Dutasteride, Tamsulosin hydrochloride Pinewood Laboratories Ltd Marketed
Dutasteride/Tamsulosin Rowa 0.5 mg/0.4 mg hard capsules.
PA0074/076/001
Tamsulosin hydrochloride, Dutasteride Rowa Pharmaceuticals Limited, Marketed
Omnexel, 400 micrograms prolonged release tablets, film-coated
PPA0465/171/001
Tamsulosin hydrochloride PCO Manufacturing Ltd. โ€”
Omnexelยฎ, 400 micrograms prolonged release tablets, film-coated
PA1241/006/001
Tamsulosin hydrochloride Astellas Pharma Co. Limited Marketed
Omnexelยฎ, 400 micrograms prolonged release tablets, film-coated
PPA1463/025/001
Tamsulosin hydrochloride IMED Healthcare Ltd., โ€”
Solifenacin succinate/Tamsulosin hydrochloride Clonmel 6 mg/0.4 mg modified-release tablets
PA0126/351/001
Solifenacin succinate, Tamsulosin hydrochloride Clonmel Healthcare Ltd Not marketed
Solifenacin succinate/Tamsulosin hydrochloride Rowex 6 mg/0.4 mg modified-release tablets
PA0711/317/001
Solifenacin succinate, Tamsulosin hydrochloride Rowex Limited, Not marketed
Tamnexyl XL 400 micrograms prolonged-release tablets
PA0126/224/001
Tamsulosin hydrochloride Clonmel Healthcare Ltd Marketed
Tamnic 400 microgram hard modified-release capsules
PA0126/395/001
Tamsulosin hydrochloride Clonmel Healthcare Ltd Not marketed
Tamnic 400 micrograms Modified-release Capsules, hard
PA0126/151/001
Tamsulosin hydrochloride Clonmel Healthcare Ltd Marketed
TAMSU 400 micrograms modified-release capsules, hard
PA0711/079/001
Tamsulosin hydrochloride Rowex Limited, Marketed
Tamsulosin 400 micrograms Modified-release Capsules, Hard
PA23266/016/001
Tamsulosin hydrochloride Viatris Limited Marketed
Tamsulosin Hydrochloride 400 micrograms Modified-release Capsules, hard
PA0840/013/001
Tamsulosin hydrochloride Synthon BV Not marketed
Tamsulosin Rowa 400 microgram modified-release hard capsules
PA0074/101/001
Tamsulosin hydrochloride Rowa Pharmaceuticals Limited, Not marketed
Tamzeltos 400 micrograms prolonged-release tablets
PA1347/087/001
Tamsulosin hydrochloride KRKA, d.d., Novo mesto Not marketed
TANYZ 400 micrograms hard modified-release capsules
PA1347/086/001
Tamsulosin hydrochloride KRKA, d.d., Novo mesto Not marketed
Vesomni 6 mg/0.4 mg modified-release tablets
PA1241/016/001
Solifenacin succinate, Tamsulosin hydrochloride Astellas Pharma Co. Limited Marketed
Vesomni 6 mg/0.4 mg modified-release tablets
PPA0465/452/001
Solifenacin succinate, Tamsulosin hydrochloride PCO Manufacturing Ltd. โ€”
Vesomni 6 mg/0.4 mg modified-release tablets
PPA1463/139/001
Solifenacin succinate, Tamsulosin hydrochloride IMED Healthcare Ltd., โ€”
Vesomni 6 mg/0.4 mg modified-release tablets
PPA23080/033/001
Solifenacin succinate, Tamsulosin hydrochloride Merit Pharmaceuticals Limited โ€”
Zeliravel 400 microgram hard modified-release capsules
PA23266/070/001
Tamsulosin hydrochloride Viatris Limited Not marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.